PMC 6632124
GLP-1 Analogue Improves Hepatic Lipid Accumulation by Inducing Autophagy via AMPK/mTOR Pathway
Review: Advances in GLP-1 receptor agonists delivery systems for obesity and diabetes A new review article published in the journal Acta Pharmaceutica Sinica B summarizes advancements in drug delivery systems for three main glucagon-like peptide-1 receptor agonists (GLP-1RAs), which are recommended for selected patients with obesity or type 2 diabetes, depending on indication, comorbidities, and treatment goals
If you lift the same weight for the same reps month after month, you are sending a maintenance signal at best
Ro and Hims are more streamlined toward convenient telehealth prescription access
Sox2, Tbr2, S100B, Ki67, activated caspase-3, and HIF1a staining required additional retrieval using 0.1% citrate buffer solution prior to incubation of the primary antibodies 70